Diane Solomon

Active 1987–2013

58
Papers
20,621
Citations
56
h-index
58
i10-index

Citations

Citations per year for Diane Solomon1987: 1 citations1988: 6 citations1989: 11 citations1990: 26 citations1991: 28 citations1992: 21 citations1993: 25 citations1994: 32 citations1995: 32 citations1996: 39 citations1997: 33 citations1998: 24 citations1999: 33 citations2000: 30 citations2001: 32 citations2002: 44 citations2003: 56 citations2004: 62 citations2005: 96 citations2006: 109 citations2007: 173 citations2008: 144 citations2009: 149 citations2010: 154 citations2011: 171 citations2012: 163 citations2013: 171 citations2014: 111 citations2015: 163 citations2016: 114 citations2017: 105 citations2018: 118 citations2019: 400 citations2020: 354 citations2021: 298 citations2022: 199 citations2023: 139 citations2024: 210 citations2025: 95 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,648 citing papers, 33.8% of this breakdownChina: 340 citing papers, 7% of this breakdownUnited Kingdom: 281 citing papers, 5.8% of this breakdownFrance: 201 citing papers, 4.1% of this breakdownGermany: 163 citing papers, 3.3% of this breakdownItaly: 162 citing papers, 3.3% of this breakdownCanada: 158 citing papers, 3.2% of this breakdownNetherlands: 153 citing papers, 3.1% of this breakdownBelgium: 124 citing papers, 2.6% of this breakdownSpain: 122 citing papers, 2.5% of this breakdownAustralia: 114 citing papers, 2.3% of this breakdownIndia: 102 citing papers, 2.1% of this breakdown
0%33.8%Other 26.9%

Fields

  • Medicine80.3%
  • Immunology and Microbiology9.5%
  • Biochemistry, Genetics and Molecular Biology5.7%
  • Computer Science2.3%
  • Health Professions0.5%
  • Engineering0.5%
  • Other1.2%

Topics

  • Cervical Cancer and HPV Research19.2%
  • Immunotherapy and Immune Responses6%
  • CAR-T cell therapy research5.3%
  • Endometrial and Cervical Cancer Treatments4.7%
  • Head and Neck Cancer Studies4.4%
  • Reproductive tract infections research4.1%
  • Other56.3%

Coauthors

All papers

Open in search
  1. Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma

    Authors: , , , , , , , , , , , , , , , - New England Journal of Medicine 1988 cited by 2,345

  2. The 2001 Bethesda SystemTerminology for Reporting Results of Cervical Cytology

    Authors: - JAMA 2002 cited by 3,135

  3. 2012 Updated Consensus Guidelines for the Management of Abnormal Cervical Cancer Screening Tests and Cancer Precursors

    Authors: , , , , , , , , - Journal of Lower Genital Tract Disease 2013 cited by 931

  4. Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine

    Authors: , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2011 cited by 326

  5. Effect of Human Papillomavirus 16/18 L1 Viruslike Particle Vaccine Among Young Women With Preexisting Infection

    Authors: , , , , , , , , , , , , - JAMA 2007 cited by 662

  6. Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa Rica

    Authors: , , , , , , , , , , , , , , , , - PLoS ONE 2013 cited by 470

  7. Cervical Cancer Prevention—Cervical Screening: Science in Evolution

    Authors: , , - Obstetrics and Gynecology Clinics of North America 2007 cited by 269

  8. Expansion of human tumor infiltrating lymphocytes for use in immunotherapy trials

    Authors: , , , - Journal of Immunological Methods 1987 cited by 363

  9. Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

    Authors: , , , - Obstetrics and Gynecology 2009 cited by 385

  10. A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia

    Authors: , , , , , , , , , , , , , , , , , - Cancer Research 2010 cited by 262

  11. CIN2 Is a Much Less Reproducible and Less Valid Diagnosis than CIN3

    Authors: , , , , , , , , , , , - International Journal of Gynecological Pathology 2007 cited by 233

  12. Risk Assessment to Guide the Prevention of Cervical Cancer

    Authors: , , , , - American Journal of Obstetrics and Gynecology 2007 cited by 180

  13. Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica

    Authors: , , , , , , , , , , , , , , - Cancer Discovery 2011 cited by 179

  14. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer

    Authors: , , , , , , , , , , , , , , , , , , - American Journal of Clinical Pathology 2012 cited by 1,398

  15. Human Papillomavirus Type 16 Infections and 2-Year Absolute Risk of Cervical Precancer in Women With Equivocal or Mild Cytologic Abnormalities

    Authors: , , , - JNCI Journal of the National Cancer Institute 2005 cited by 328

  16. Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

    Authors: , , , , , , , , , , , , , , , , , , , , , - Vaccine 2008 cited by 168

  17. The 2001 Bethesda System: Terminology for Reporting Results of Cervical Cytology

    Authors: , , , , , , , , , - Obstetrical & Gynecological Survey 2002 cited by 841

  18. The Relationship of Community Biopsy-Diagnosed Cervical Intraepithelial Neoplasia Grade 2 to the Quality Control Pathology-Reviewed Diagnoses

    Authors: , , , , - American Journal of Clinical Pathology 2007 cited by 204

  19. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 cited by 193

  20. Human papillomavirus infection and the primary and secondary prevention of cervical cancer

    Authors: , , , , - Cancer 2008 cited by 160

  21. Cervical-Cancer Screening with Human Papillomavirus and Cytologic Cotesting

    Authors: , - New England Journal of Medicine 2013 cited by 125

  22. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests

    Authors: , , , , , - American Journal of Obstetrics and Gynecology 2007 cited by 850

  23. Number of Cervical Biopsies and Sensitivity of Colposcopy

    Authors: , , , , , , , , - Obstetrics and Gynecology 2006 cited by 352

  24. Human Papillomavirus Genotype Specificity of Hybrid Capture 2

    Authors: , , , , , - Journal of Clinical Microbiology 2008 cited by 174